High materiality8/10
MBX Biosciences Inc (MBX) PT Raised to $150 at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises MBX target to $150; current price is $56.55. Price has increased about 3.47% since the signal.
- Guggenheim raises target to $150; price $56.55; +3.47% since signal.
Key facts
- 01
Target: $150
- 02
Posted price: $56.55
- 03
Analyst firm: Guggenheim
- 04
Analyst: Seamus Fernandez
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.